CARB-X logo

CARB-X

CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria. With more than $500 million to invest, CARB-X funds the best science from around the world. The CARB-X portfolio is the world’s largest early development pipeline of new antibiotics, vaccines, rapid diagnostics and other products to prevent and treat life-threatening bacterial infections.

KEY DETAILS

Websitehttps://carb-x.org
Founded
Disease Focus
Development Stage
STOCK CODENon Listed
Address
765 Commonwealth Avenue, Suite 1204, 02215
Boston
United States
Email
Contact Number